Stoneridge Inc has 9 Schedule 13D or 13G filings on record since 2025-07-16. 2 holders' latest filing reports 5% or more of common stock. Each figure below is the holder's own, as filed, with the filing linked.
Holders
| Holder | Percent | Shares | Latest | Event date |
|---|---|---|---|---|
| 22NW Fund, LP | 8.2% | 2,297,092 | SCHEDULE 13D/A, 2026-02-27 | 2026-02-26 |
| BlackRock, Inc. | 7% | 1,962,933 | SCHEDULE 13G, 2026-07-30 | 2026-06-30 |
| Dimensional Fund Advisors LP | 4.8% | 1,344,135 | SCHEDULE 13G/A, 2025-10-09 | 2025-09-30 |
| Royce & Associates LP | 3.7% | 1,035,697 | SCHEDULE 13G/A, 2025-10-22 | 2025-09-30 |
| The Vanguard Group | 0% | 0 | SCHEDULE 13G/A, 2026-03-27 | 2026-03-13 |
Purpose of Transaction (Item 4)
22NW Fund, LP
Item 4 is hereby amended to add the following: On February 26, 2026, the Reporting Persons entered into a cooperation agreement (the "Cooperation Agreement") with the Issuer. Pursuant to the Cooperation Agreement, the Issuer agreed to increase the size of the Issuer's board of directors (the "Board") from seven (7) to eight (8) directors and to appoint Aron R. English to the Board to fill the resulting vacancy, effective on March 16, 2026, with an initial term expiring at the Issuer's 2026 Annual Meeting of Shareholders (the "2026 Annual Meeting"). The Issuer has also agreed to nominate and include Mr. English in the Board's slate of director nominees for election at the 2026 Annual Meeting and to recommend that shareholders vote in favor of his election, and to otherwise support and solicit proxies for his election in a manner no less favorable than the manner in which the Issuer supports its other director nominees. Pursuant to the Cooperation Agreement, the Reporting Persons are subject to certain standstill restrictions from the date of the Cooperation Agreement until the date that is 30 days after the earliest to occur of (a) the date on which Mr. English is no longer a member of the Board, (b) the date that is 60 days prior to any advance notice deadline for the nomination of director candidates set by the Issuer with respect to its 2027 Annual Meeting of Shareholders, or (c) the termination of the Cooperation Agreement (such period, the "Standstill Period"). During …The first part of Item 4 of the SCHEDULE 13D/A filed 2026-02-27; the filing has the rest
Timeline
| Filed | Holder | Percent | Filing |
|---|---|---|---|
| 2025-07-16 | BlackRock, Inc. | 2.3% | SCHEDULE 13G/A |
| 2025-07-22 | Royce & Associates LP | 5.02% | SCHEDULE 13G |
| 2025-08-13 | 22NW Fund, LP | 7% | SCHEDULE 13G/A |
| 2025-10-09 | Dimensional Fund Advisors LP | 4.8% | SCHEDULE 13G/A |
| 2025-10-22 | Royce & Associates LP | 3.7% | SCHEDULE 13G/A |
| 2026-02-06 | 22NW Fund, LP | 8.2% | SCHEDULE 13D |
| 2026-02-27 | 22NW Fund, LP | 8.2% | SCHEDULE 13D/A |
| 2026-03-27 | The Vanguard Group | 0% | SCHEDULE 13G/A |
| 2026-07-30 | BlackRock, Inc. | 7% | SCHEDULE 13G |
Tools for this story
Each opens in a new tab, filled in for Stoneridge Inc. With no account yet, you sign up free and land on the result.
Where this comes from
Anyone who comes to own more than 5% of a class of a listed company's voting shares has to tell the SEC. A holder who may seek to change or influence the company files Schedule 13D, and has to say in Item 4, "Purpose of Transaction", what it intends to do. A holder with no such intent, such as many index and passive funds, may file the shorter Schedule 13G. Both are amended when the stake changes, including when it falls below 5%.
Every row here is one of those filings, linked to the filing itself. Percentages and share counts are exactly as the holder filed them, for the holder the filing names; an amendment showing a lower figure is shown as filed. Item 4 text is quoted word for word. Where a 13D's Item 4 contains a sentence stating a definite intent to influence the company, that sentence is marked and quoted; the page does not describe the holder or its motives beyond the words it filed. Nothing here is investment advice.